TRAW

TRAWS PHARMA INC

TRAW·68232V884·US·Common Stock·Healthcare - Biotechnology-Activist

TRAW (TRAWS PHARMA INC) is held by 15 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($141,100), VANGUARD CAPITAL MANAGEMENT LLC ($101,003). Net institutional sentiment: Mixed.

15
Holders
Avg rating(2 Elite)
$1.8M
Total Value
59% (21)
Fund Consensus
10 buying - 7 selling
TRAWSmart Money Verdict
View all
Held by 15 funds
2 elite
Who's Trading
ActivistPAPerceptive Advisors LLC6.1%May 15, 2026
ActivistSMSquadron Master Fund LP6.4%May 15, 2026
ActivistOAORBIMED ADVISORS LLC11.9%May 5, 2026
InsiderOLORBIMED ADVISORS LLCBuy $998KApr 16, 2026
ActivistIKIkarian Capital, LLC10.0%Feb 17, 2026
ActivistADAdage Capital Management, L.P.9.1%Feb 12, 2026
ActivistAYAyrton Capital LLC4.3%Feb 11, 2026
ActivistCJChernett Jorey6.8%Jan 16, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
730,000$1.3M0.0%-54.82%
0
Increased
77,103(+25.1%)$141,1000.0%-78.18%
19
New
55,193$101,0030.0%-53.94%
33
New
31,804$58,2010.0%-53.94%
32
Unchanged
25,802$47,2180.0%-30.28%
0
New
21,241$38,8710.0%-53.94%
31
Unchanged
19,244$35,2170.0%-51.11%
0
Unchanged
9,956$18,2190.0%-90.97%
0
Decreased
4,053(-47.5%)$7,4170.0%-30.36%
0
New
3,729$6,8240.0%-53.94%
24
New
262$4790.0%-53.94%
17
Increased
23(+1050.0%)$420.0%-55.69%
12
New
2$40.0%-53.94%
17
New
2$40.0%-53.94%
17
Exited
0(-100.0%)$90.0%+51.38%
0
Exited
0(-100.0%)$10.0%-12.34%
0
Exited
0(-100.0%)$28,0450.0%+51.38%
0
New
6$00.0%-53.94%
17
Exited
0(-100.0%)$1280.0%-73.09%
0
Exited
0(-100.0%)$16,0430.0%+51.38%
0

Showing 1-20 of 21

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used